Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ExonHit extends alliance with Allergan
The agreement comes after positive preclinical trials for the products which are focused on the treatment of neurological diseases such as Alzheimer’s. The previous success of the partnership
The agreement comes after positive preclinical trials for the products which are focused on the treatment of neurological diseases such as Alzheimer’s. The previous success of the partnership
Epirubicin is a chemotherapy drug that is given as a treatment for many different types of cancer and is administered by injection. Epirubicin, sold under the brand name
Auriga commented that Xerostomia could represent a potential marketplace estimated at more than $1 billion. The current size of the prescription marketplace for xerostomia medications is at approximately
The sum of payment has not been published but under the terms of the agreement, Alcon Manufacturing will make an up front payment to NovaCal. Alcon will also
Data from a trial revealed that after a 24 month observation period there was improved bone growth in the patients treated with GEM 21S. GEM 21S works by
The compound has been granted fast track status by the FDA in this patient population. Tykerb is a small molecule dual kinase inhibitor developed by GSK as an
Linda Reeves was the plaintiff who was diagnosed with breast cancer after the use of the hormone therapy Prempro. This was the first case of a series of
Pfizer will receive exclusive worldwide rights to commercialize TransTech's portfolio of compounds, while TransTech will receive upfront and milestone payments of $155 million with the potential for more.
Invasive fungal infections most often occur in people who are immunocompromised or immunosuppressed, and are increasingly caused by moulds such as Aspergillus. Patients undergoing stem cell transplant or
Bausch & Lomb will evaluate the compound's potential as a novel anti-inflammatory medication with an improved safety profile for ophthalmic indications. Glucocorticoids are the most potent and frequently